Marc Toeteberg-Harms

Associate Professor

Marc Toeteberg-Harms

Associate Professor

Academic Appointment(s)

Medical College of Georgia
Department of Ophthalmology


Marc Töteberg-Harms, MD is a glaucoma specialist and Associate Professor at the Department of Ophthalmology, Medical College of Georgia at Augusta University. In addition, he is a lecturer (Privatdozent) with the University of Zurich in Switzerland. He went to Charité Medical School, Humboldt University Berlin, Germany and to the Christian-Albrechts-University of Kiel, Germany, where he graduated from. He earned his medical doctorate degree and the venia legendi at the University of Zurich Medical School. Later, he completed a two-year clinical and basic research glaucoma fellowships at both Massachusetts Eye and Ear Infirmary, Boston, MA, and Case Western Reserve University, Cleveland, OH, in the United States. He is a fellow of the Next Generation Partnership Program (NGP) of the European Glaucoma Society (EGS) , the NGP co-chair of the the EGS Industry Liaison Committee and a member of the EGS guidelines committee. Furthermore, he was a member of the executive committee of the Glaucoma Group of the Swiss Society of Ophthalmology (treasury) from 2018 until 2021. He was awarded honorary membership of the Romanian Glaucoma Society. He has authored or co-authored numerous publications and has given more than fifty invited lectures and instructional courses at international meetings.

  • (706) 721-6175
  • (706) 721-1158
  • BA-2723


  • MD, Medicine Christian Albrecht University, 2007


  • PHY GA Professional Licensing BRD, 2023

  • PHY GA Professional Licensing BRD, 2021

Awards & Honors

  • Educator of the Year 2022-2023 Dept. of Ophthalmology, Medical College of Georgia, Augusta University, 2023

Courses Taught Most Recent Academic Year

  • ROPH 5000

  • OPTH 5001

    Ophthalmology Externship

Teaching Interests

Diagnosis and treatment of glaucoma


Selected Recent Publications

  • MicroPulse Transscleral Laser Therapy Demonstrates Similar Efficacy with a Superior and More Favorable Safety Profile Compared to Continuous-Wave Transscleral Cyclophotocoagulation., 2022
    Journal Article, Academic Journal
  • The AIDA and the extra laser systems for excimer laser trabeculotomy proved comparable IOP lowering efficacy-12-month results., 2022
    Journal Article, Academic Journal
  • First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma., 2022
    Journal Article, Academic Journal
  • Selective laser trabeculoplasty following failed combined phacoemulsification cataract extraction and excimer laser trabeculotomy can control intraocular pressure for a limited time., 2022
    Journal Article, Academic Journal
  • Long-term treatment success and safety of combined phacoemulsification plus excimer laser trabeculostomy: an 8-year follow-up study., 2022
    Journal Article, Academic Journal

Research Interests

Glaucoma; congenital glaucoma; medical, surgical, and laser treatment for glaucoma; glaucoma diagnosis and management; Quality of Life and glaucoma treatment; minimally-invasive glaucoma surgery (MIGS)​​​​